Paul A. Vasey
Auchenflower, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pembrolizumab and Denosumab in Clear-Cell Renal-Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: January 16, 2026
What Do Medical Oncologists Expect From PET/CT Reports.
Journal: Journal of medical imaging and radiation oncology
Published: October 23, 2025
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: August 11, 2025
Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?
Journal: Investigative and clinical urology
Published: February 28, 2021
Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover.
Journal: Cancers
Published: May 28, 2020
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 10, 2016
TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer.
Journal: Cancer chemotherapy and pharmacology
Published: May 19, 2016
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 26, 2014
Incorporation of pazopanib in maintenance therapy of ovarian cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 17, 2014
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 21, 2013
Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: results of a phase III randomised European Organisation for Research and Treatment of Cancer (Genito-Urinary Cancers Group)/National Cancer Research Institute trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 15, 2013
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 09, 2012
Last Updated: 09/26/2026